-
A SEQUENTIAL MATCHING APPROACH TO ADDRESS IMMORTAL TIME BIAS: APPLICATION TO THE MGUS STUDY
Mar 18, 2026, 21:38 PM -
COMPARISON OF 5-YEAR SURVIVAL AND ESTIMATED LIFE YEARS BETWEEN TWO DATA CUTS OF STUDY 309/KEYNOTE-775
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ABIRATERONE, APALUTAMIDE, ENZALUTAMIDE, AND DOCETAXEL DOUBLETS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A REAL-WORLD EVIDENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
COMPARISON OF GUIDELINE-RECOMMENDED AND PRELIMINARY RISK-BASED APPROACHES TO SELECTION OF LUNG CANCER PATIENTS FOR LYMPH NODE STAGING
Mar 18, 2026, 21:38 PM -
COST COMPARISON OF RFVIIA AND PLASMA-DERIVED FACTOR VII FOR BLEEDING MANAGEMENT IN COLOMBIA
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE IMPACT OF ADHERENCE TO HEREDITARY CANCER TESTING ON COLORECTAL CANCER BURDEN: A MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
COMPARING ESTABLISHED AND NOVEL INDEX DATE SELECTION METHODS: A SIMULATION STUDY IN TWO CLINICAL CONTEXTS
Mar 18, 2026, 21:38 PM -
STUDENT-REPORTED BARRIERS TO ISPOR CONFERENCE ATTENDANCE: A NORTH AMERICA VS. REST OF WORLD ANALYSIS
Mar 18, 2026, 21:38 PM -
SAME EVIDENCE, DIFFERENT DECISIONS: HOW REGULATORY STANDARDS SHAPE ORPHAN DRUG APPROVALS
Mar 18, 2026, 21:38 PM -
REAL-TIME AND SHORT RECALL OF FLARES IN PNH, CAPTURED THROUGH LONGITUDINAL HOME-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT REPORTING HABITS IN CLINICAL TRIALS: A COMPARISON OF EVENT-DRIVEN VS. PROMPTED EVENING EDIARY ENTRIES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TIRZEPATIDE FOR THE MANAGEMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY
Mar 18, 2026, 21:38 PM -
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD HYPERTENSIVE THERAPY AMONG TYPE 2 DIABETIC PATIENTS WITH HYPERTENSION
Mar 18, 2026, 21:38 PM -
PREDICTING TREATMENT-RESISTANT DEPRESSION AMONG MEDICARE BENEFICIARIES USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
CLAIMS DATA FOR POST-MARKET SAFETY INVESTIGATIONS: LESSONS FROM A REAL-WORLD ONCOLOGY COHORT
Mar 18, 2026, 21:38 PM -
A STATISTICAL MODELING FRAMEWORK FOR PROCESS-MINED REAL-WORLD DATA SUPPORTING HTA OF MULTIPLE MYELOMA TECHNOLOGIES IN A BRAZILIAN HEALTH MAINTENANCE ORGANIZATION
Mar 18, 2026, 21:38 PM -
ARTIFICIAL INTELLIGENCE (AI) IN ONCOLOGY HEALTH TECHNOLOGY ASSESSMENT (HTA): CURRENT APPLICATIONS, LIMITATIONS, AND IMPLICATIONS FOR LIVING-HTA
Mar 18, 2026, 21:38 PM -
THE COST OF PERFORMING FEES: ESTIMATING ANNUALIZED COSTS OF MOBILE FEES PROVIDERS FOR LTACH AND SNFS
Mar 18, 2026, 21:38 PM -
AN EFFECTIVE METHODOLOGICAL FRAMEWORK FOR EXECUTING MULTINATIONAL, PATIENT-CENTRED CROSS-SECTIONAL SURVEYS IN RARE DISEASES: FACILITATING EVIDENCE GENERATION WITH GENERALISABILITY ACROSS CONDITIONS TO SUPPORT COMMERCIAL VIABILITY
Mar 18, 2026, 21:38 PM
